Clinical trials: Placenta Increta
Postpartum Hemorrhage (PPH), Placental Dysfunction
Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta
This retrospective, monocentric study aims to examine risk factors for postpartum hemorrhage in women with histologically verified placenta accreta.
- Trial name
- NCT05542043
- Testing
- Data collection
- Where
- Switzerland
- Volunteers
- 2,348 people
- Sponsor
- University Hospital, Basel, Switzerland
Scar; Previous Cesarean Section, Complications; Cesarean Section, Wound, Dehiscence
Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section
This prospective, controlled, clinical, intervention study measures the number of uterine Cesarean section scars and median myometrial thickness of women who underwent two Cesarean sections six to nine months after their last…
- Trial name
- OPSTAR (NCT02703519)
- Testing
- resection of uterine scar tissue
- Where
- 2 sites in Germany
- Volunteers
- 116 people
- Sponsor
- Martin-Luther-Universität Halle-Wittenberg
Placenta Previa, Placenta Accreta
ROTEM in Patients With Placenta Previa
The rotational thromboelastogram (ROTEM) test can be performed on patients with placenta previa/accreta/increta/percreta who have a high likelihood of massive bleeding, and the predictors can be identified by comparing the…
- Conditions
- Placenta Previa, Placenta Accreta, Placenta Increta, Placenta Percreta
- Trial name
- NCT04213755
- Testing
- ROTEM
- Where
- South Korea
- Volunteers
- 100 people
- Sponsor
- Seoul National University Bundang Hospital
Placenta Accreta
Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta
The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.
- Trial name
- NCT04082507
- Testing
- Serum alpha-fetoproteine
- Where
- Egypt
- Volunteers
- 150 people
- Sponsor
- rasha medhat abdul-hady
Placenta Accreta, Placenta Percreta
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Cell free fetal DNA might predict abnormal placental invasion
- Conditions
- Placenta Accreta, Placenta Percreta, Placenta Increta, Placenta Previa
- Trial name
- NCT03638024
- Testing
- Maternal plasma cell free fetal DNA levels
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Ain Shams Maternity Hospital
Placenta Previa
ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta).
Placenta previa totalis (accreta, increta, percreta); ADAMTS and proteoglycans and the oxidant / antioxidant enzyme levels.
- Trial name
- NCT02270593
- Where
- Turkey (Türkiye)
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
Morbidly Adherent Placenta, Placenta Accreta
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
The purpose of this study is to determine whether, in a high risk population (placenta praevia and previous caesarean or prenatal suspicion of morbidly adherent placenta (MAP)), the concentration of cell-free fetal DNA…
- Conditions
- Morbidly Adherent Placenta, Placenta Accreta, Placenta Increta, Placenta Percreta
- Trial name
- DNA-Accreta (NCT02784886)
- Testing
- Women at high risk of MAP
- Where
- France
- Volunteers
- 63 people
- Sponsor
- University Hospital, Angers